The Good Brigade/DigitalVision via Getty Images
INmune Bio’s September 2021 news for XPro
I am very bullish about INmune Bio (INMB). I first reported on INmune Bio in July 2021 in view of their upcoming Alzheimer’s disease (AD) readout with their drug…
INmune Bio A No-Brainer Investment
Share this article
More News

SpaceX Stock (SPCX) Moved Up by 3.88% on Sep 17: A Full Analysis
September 17, 2026




Nebius Stock Jumps On Cloud Computing Price Hikes
September 17, 2026

Optimism creeps back into crypto, with the 2022 test still to come
September 17, 2026

Boeing Stock Breaks $204.50 as Production Delays Put $197 Support in Focus
September 17, 2026